| Esmeralda Acevedo Negron, | |
|
Carr 2 Km 94 Hm 5, Bo Yeguada, Camuy, PR 00627-0062 | |
| (787) 820-4776 | |
| (787) 820-4776 |
| Full Name | Esmeralda Acevedo Negron |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 28 Years |
| Location | Carr 2 Km 94 Hm 5, Camuy, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659844017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 001053 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centro De Terapia Fisica Del Norte Llc | 9133549504 | 2 |
News Archive
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
"The growing burden of cancer in developing countries could be reduced without expensive drugs and equipment, scientists said on Monday, but it requires a global effort similar to the fight against HIV/AIDS," Reuters reports in an article that examines a study published in the Lancet by a group of American scientists who have created the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries.
While we're not necessarily aware of our heartbeat, this inner rhythm actually contributes to how we experience the body, and what belongs to it, according to research recently conducted at EPFL.
Aspen Brook Consulting, Inc., announces the 2010 Bioprocess Management Summit. This event, occurring February 24th-26th, 2010 at The Canyons Hotel and Conference Center in Park City UT, has been designed as a forum where members of the bioprocess community gather annually to share their knowledge and experience in an effort to address challenges facing the biopharmaceutical industry.
› Verified 7 days ago
| Provider Name | Centro De Terapia Fisica Del Norte Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1083225809 PECOS PAC ID: 9133549504 Enrollment ID: O20201023001686 |
News Archive
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
"The growing burden of cancer in developing countries could be reduced without expensive drugs and equipment, scientists said on Monday, but it requires a global effort similar to the fight against HIV/AIDS," Reuters reports in an article that examines a study published in the Lancet by a group of American scientists who have created the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries.
While we're not necessarily aware of our heartbeat, this inner rhythm actually contributes to how we experience the body, and what belongs to it, according to research recently conducted at EPFL.
Aspen Brook Consulting, Inc., announces the 2010 Bioprocess Management Summit. This event, occurring February 24th-26th, 2010 at The Canyons Hotel and Conference Center in Park City UT, has been designed as a forum where members of the bioprocess community gather annually to share their knowledge and experience in an effort to address challenges facing the biopharmaceutical industry.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Esmeralda Acevedo Negron, Hc 2 Box 7053, Lares, PR 00669-9731 Ph: (939) 277-8086 | Esmeralda Acevedo Negron, Carr 2 Km 94 Hm 5, Bo Yeguada, Camuy, PR 00627-0062 Ph: (787) 820-4776 |
News Archive
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
"The growing burden of cancer in developing countries could be reduced without expensive drugs and equipment, scientists said on Monday, but it requires a global effort similar to the fight against HIV/AIDS," Reuters reports in an article that examines a study published in the Lancet by a group of American scientists who have created the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries.
While we're not necessarily aware of our heartbeat, this inner rhythm actually contributes to how we experience the body, and what belongs to it, according to research recently conducted at EPFL.
Aspen Brook Consulting, Inc., announces the 2010 Bioprocess Management Summit. This event, occurring February 24th-26th, 2010 at The Canyons Hotel and Conference Center in Park City UT, has been designed as a forum where members of the bioprocess community gather annually to share their knowledge and experience in an effort to address challenges facing the biopharmaceutical industry.
› Verified 7 days ago
Benito Cortes, Physical Therapist Medicare: Medicare Enrolled Practice Location: 335 Ext Vistas De Camuy, Camuy, PR 00627 Phone: 787-235-7694 Fax: 787-881-5572 | |
Johana Echevarria Cubero, RPT Physical Therapist Medicare: Medicare Enrolled Practice Location: Hc 1 Box 3323, Camuy, PR 00627 Phone: 787-209-8190 | |
Mrs. Doritza Escobar, M.S. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Urb. Vistas De Camuy G-7 Camuy, P.r. 00627, Camuy, PR 00627 Phone: 787-404-3871 | |
Mrs. Yadira C Guadalupe, R.P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 2 Calle 2, Camuy, PR 00627 Phone: 787-820-4776 Fax: 787-820-4776 | |
Mrs. Lizzette Lopez, Physical Therapist Medicare: Medicare Enrolled Practice Location: H69 Calle 8, Urb Del Carmen, Camuy, PR 00627 Phone: 787-560-0724 | |
Mrs. Isamar Vanessa Rivera, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Hc 3 Box 12000, Bo. Yeguada, Camuy, PR 00627 Phone: 787-447-8064 Fax: 800-730-6853 | |
Gladys S Ruiz Hernandez, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: Carr # 119 Ramal 486 Km 2 Hm 1 Interior, Bo. Zanjas,carr Pipo Crespo,sector Viequez, Camuy, PR 00627 Phone: 787-602-7467 Fax: 787-898-3438 |